A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer’s disease from young adulthood and for designing prevention trials.

Xiong, C., J. Luo, F. Agboola, Y. Li, M. Albert, S. Johnson, R. Koscik, C. Masters, A. Soldan, V. Villemagne, Q. Li, E. McDade, A. Fagan, P. Massoumzadeh, T. Benzinger, J. Hassenstab, R. Bateman, J. Morris, and I. Dominantly. “A Harmonized Longitudinal Biomarkers and Cognition Database for Assessing the Natural History of Preclinical Alzheimer’s Disease from Young Adulthood and for Designing Prevention Trials.”. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, Vol. 15, no. 11, 2019, pp. 1448-57.

Large longitudinal biomarkers database focusing on middle age is needed for Alzheimer’s disease (AD) prevention.

DOI: 10.1016/j.jalz.2019.06.4955

PubMed: 31506247